B4GALT1 and colorectal carcinoma: In three out of four datasets Kaplan–Meier curves showed a significantly worse survival duration in patients with B4GALT1 low expression than in B4GALT1 high patients (cohort 1 DFS p = 0.164; cohort 2 DFS p = 0.002; cohort 3 DFS p = 0.003; cohort 4 CSS p = 0.008) (Figure 2A–D), indicating that the downregulation of B4GALT1 gene expression is related to poor prognosis for CRC.